Related Articles
Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer.
Her-2/neu amplification and breast cancer survival: Results from the Shanghai breast cancer study
Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients
Circulating HER‑2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer
EGFR activity in HER-2 over-expressing metastatic breast cancer: evidence for simultaneous phosphorylation of Her-2/neu and EGFR